Lumonus, an AI-powered radiation oncology workflow solutions company, closed a A$25 million Series B funding round led by Aviron Investment Management with continued participation from Oncology Ventures to expand its US commercial footprint and advance its flagship products.
Related articles
Press ReleaseSeptember 16, 2026
ASSA ABLOY
ASSA ABLOY acquires PACLOCK in the US
September 16, 2026
Press ReleaseSeptember 16, 2026
MySize
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv
Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform
September 16, 2026
← Back to all articles
Generated by Olivia 6